Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Helen of Troy gets Sure, Pert Plus

This article was originally published in The Tan Sheet

Executive Summary

The El Paso, Texas-based company expects acquisition of Innovation Brands' Sure antiperspirant/deodorant and Pert Plus hair-care brands to be accretive upon integration, generating roughly $65 million for its Idelle Labs division. Sure is "one of the leading brands in the $1.7 billion U.S. antiperspirant and deodorant category," Helen of Troy says. "Adding [the brands] will enhance our role as a comprehensive provider of solutions for our hair-care and personal grooming consumers and styling professionals." Deal is expected to close by the end of the month, according to March 10 release. Helen picked up Infusium 23 hair care from Procter & Gamble in 2009. Its personal-care portfolio also includes Brut men's grooming, Ogilvie hair-straightening treatments and Sea Breeze astringents

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103893

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel